Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting tumor and bone microenvironment: Novel therapeutic opportunities for castration-resistant prostate cancer patients with bone metastasis
Shenglong Li, Yue Kang, Yu Zeng
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1879, Iss. 1, pp. 189033-189033
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Tumor immunotherapy resistance: Revealing the mechanism of PD-1 / PD-L1-mediated tumor immune escape
Jiawen Cui, Yao Li, Yang Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116203-116203
Open Access | Times Cited: 35
Identification of metastasis-related genes for predicting prostate cancer diagnosis, metastasis and immunotherapy drug candidates using machine learning approaches
Yaxuan Wang, Bo Ji, Lu Zhang, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 21
Cellular senescence in the tumor with a bone niche microenvironment: friend or foe?
Sajad Alavimanesh, Negar Nayerain Jazi, Maedeh Choubani, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Nano-Drug Delivery Systems Targeting CAFs: A Promising Treatment for Pancreatic Cancer
Mingjie Wang, Wenxiang Xue, Hanghang Yuan, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2823-2849
Open Access | Times Cited: 10
The role of cancer-associated fibroblasts and exosomal miRNAs-mediated intercellular communication in the tumor microenvironment and the biology of carcinogenesis: a systematic review
Reza Nedaeinia, Simin Najafgholian, Rasoul Salehi, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 10
Hit to lead optimization of the 4-trifluoromethylquinoline derivatives as novel SGK1 inhibitors with potent anti-prostate cancer activity
Cheng Li, Sha Cheng, Jia Yu, et al.
European Journal of Medicinal Chemistry (2025), pp. 117336-117336
Closed Access | Times Cited: 1
Engineering nanoparticles for cancer immunotherapy: Current achievements, key considerations and future perspectives
Muhammad Umar Farooq, Charles H. Lawrie, Nan‐Nan Deng
Chemical Engineering Journal (2024) Vol. 486, pp. 150356-150356
Closed Access | Times Cited: 7
Nanoparticles and bone microenvironment: a comprehensive review for malignant bone tumor diagnosis and treatment
Yujing Guan, Wei Zhang, Yuling Mao, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Exosomal non-coding RNA: A new frontier in diagnosing and treating pancreatic cancer: A review
Gengyu Sha, Wenjie Zhang, Zhengting Jiang, et al.
International Journal of Biological Macromolecules (2024) Vol. 263, pp. 130149-130149
Closed Access | Times Cited: 5
TBX3 shapes an immunosuppressive microenvironment and induces immunotherapy resistance
Zhi Liu, Chunyu Zhang, Jiatong Xiao, et al.
Theranostics (2025) Vol. 15, Iss. 5, pp. 1966-1986
Open Access
Focus on mechano-immunology: new direction in cancer treatment
Lin Zhao, Yajun Gui, Xiangying Deng
International Journal of Surgery (2025) Vol. 111, Iss. 3, pp. 2590-2602
Open Access
Circular RNA microarray expression profile and potential function of circDOCK1 in colorectal cancer
Guojing Zhang, Xiaoyan Wu, Hongmin Fu, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
Resveratrol loaded zein nanoparticles for inhibiting proliferation of osteosarcoma cells: synthesis, characterization, release profile, and cytotoxicity
Thanida Chuacharoen, Carlos E. Astete, Cristina M. Sabliov
OpenNano (2025), pp. 100237-100237
Open Access
Exploring Immune Checkpoint Inhibitors: Focus on PD-1/PD-L1 Axis and Beyond
Durre Aden, Samreen Zaheer, Niti Sureka, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155864-155864
Closed Access
Deciphering the mechanisms of PARP inhibitor resistance in prostate cancer: Implications for precision medicine
Cheng Wang, Xiaoran Han, Shaoqiu Kong, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 185, pp. 117955-117955
Closed Access
A novel bone metastasis-related gene signature for predicting prognosis, anti-androgen resistance, and drug choice in prostate cancer
Yu Luo, Xiaoqi Deng, Chengcheng Wei, et al.
Journal of bone oncology (2025), pp. 100673-100673
Open Access
Unraveling the triad of immunotherapy, tumor microenvironment, and skeletal muscle biomechanics in oncology
Shuang Ma, Ying Lü, S.J. Sui, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Immunoreactive Microenvironment Modulator GBP5 Suppresses Ovarian Cancer Progression by Inducing Canonical Pyroptosis
Chang Zou, Jiacheng Shen, Fangfang Xu, et al.
Journal of Cancer (2024) Vol. 15, Iss. 11, pp. 3510-3530
Open Access | Times Cited: 3
The Immune Microenvironment in Prostate Cancer: A Comprehensive Review
René Novysedlák, Miray Guney, Majd Al Khouri, et al.
Oncology (2024), pp. 1-25
Open Access | Times Cited: 3
Recent Progress of Bioinspired Cell Membrane in Cancer Immunotherapy
Min Zhang, Yuanhang Wang, Zhiyuan Song, et al.
Clinical Medicine Insights Oncology (2024) Vol. 18
Open Access | Times Cited: 2
System analysis based on Anoikis-related genes identifies MAPK1 as a novel therapy target for osteosarcoma with neoadjuvant chemotherapy
Zhouwei Wu, Jiapei Yu, Tao Han, et al.
BMC Musculoskeletal Disorders (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
In vivo validation of the functional role of MicroRNA-4638-3p in breast cancer bone metastasis
R.L. Akshaya, I. Saranya, G. Margaret Salomi, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 2
Open Access | Times Cited: 1
Deciphering chemoresistance in osteosarcoma: Unveiling regulatory mechanisms and function through the lens of noncoding RNA
Hefen Chen, Zhujun Gong, Hong Zhou, et al.
Drug Development Research (2024) Vol. 85, Iss. 2
Closed Access | Times Cited: 1
Advances in immunotherapy for mucosal melanoma: harnessing immune checkpoint inhibitors for improved treatment outcomes
Zexing Shan, Fei Liu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Extrachromosomal circular DNA-related SPOCK1 contributes to development and enzalutamide resistance of prostate cancer by regulating epithelial mesenchymal transition
Yicong Yao, Qinghua Wang, Wei Jiang, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37075-e37075
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top